194 related articles for article (PubMed ID: 23973525)
1. The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination.
Wang L; Pan X; Sweet DH
Biochem Pharmacol; 2013 Oct; 86(7):991-6. PubMed ID: 23973525
[TBL] [Abstract][Full Text] [Related]
2. Interaction of five anthraquinones from rhubarb with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8) and drug-drug interaction in rats.
Ma L; Zhao L; Hu H; Qin Y; Bian Y; Jiang H; Zhou H; Yu L; Zeng S
J Ethnopharmacol; 2014 May; 153(3):864-71. PubMed ID: 24685584
[TBL] [Abstract][Full Text] [Related]
3. Interaction between rhein acyl glucuronide and methotrexate based on human organic anion transporters.
Yuan Y; Yang H; Kong L; Li Y; Li P; Zhang H; Ruan J
Chem Biol Interact; 2017 Nov; 277():79-84. PubMed ID: 28890383
[TBL] [Abstract][Full Text] [Related]
4. Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Motohashi H; Tsuji Y; Ueo H; Katsura T; Inui K
Biochem Pharmacol; 2007 Jun; 74(1):161-8. PubMed ID: 17462604
[TBL] [Abstract][Full Text] [Related]
5. Time-Dependent Inhibition of hOAT1 and hOAT3 by Anthraquinones.
Ma L; Qin Y; Shen Z; Hu H; Zhou H; Yu L; Jiang H; Zeng S
Biol Pharm Bull; 2015; 38(7):992-5. PubMed ID: 26133709
[TBL] [Abstract][Full Text] [Related]
6. Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8).
Srimaroeng C; Chatsudthipong V; Aslamkhan AG; Pritchard JB
J Pharmacol Exp Ther; 2005 May; 313(2):621-8. PubMed ID: 15644426
[TBL] [Abstract][Full Text] [Related]
7. Competitive inhibition of human organic anion transporters 1 (SLC22A6), 3 (SLC22A8) and 4 (SLC22A11) by major components of the medicinal herb Salvia miltiorrhiza (Danshen).
Wang L; Sweet DH
Drug Metab Pharmacokinet; 2013; 28(3):220-8. PubMed ID: 23229784
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective Inhibition of Renal Basolateral Human Organic Anion Transporter 3 by Lansoprazole Enantiomers.
Hamada Y; Ikemura K; Iwamoto T; Okuda M
Pharmacology; 2018; 101(3-4):176-183. PubMed ID: 29353278
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors inhibit methotrexate transport by renal basolateral organic anion transporter hOAT3.
Chioukh R; Noel-Hudson MS; Ribes S; Fournier N; Becquemont L; Verstuyft C
Drug Metab Dispos; 2014 Dec; 42(12):2041-8. PubMed ID: 25239859
[TBL] [Abstract][Full Text] [Related]
10. Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Honjo H; Iwamoto K
Pharmacol Res; 2012 Feb; 65(2):254-60. PubMed ID: 22108572
[TBL] [Abstract][Full Text] [Related]
11. Molecular assessment of the potential for renal drug interactions between tenofovir and HIV protease inhibitors.
Cihlar T; Ray AS; Laflamme G; Vela JE; Tong L; Fuller MD; Roy A; Rhodes GR
Antivir Ther; 2007; 12(2):267-72. PubMed ID: 17503669
[TBL] [Abstract][Full Text] [Related]
12. Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3).
Hong SS; Seo K; Lim SC; Han HK
Pharmacol Res; 2007 Dec; 56(6):468-73. PubMed ID: 17920288
[TBL] [Abstract][Full Text] [Related]
13. Effects of phenylpropanoids on human organic anion transporters hOAT1 and hOAT3.
Kawasaki T; Takeichi Y; Tomita M; Uwai Y; Epifano F; Fiorito S; Taddeo VA; Genovese S; Nabekura T
Biochem Biophys Res Commun; 2017 Aug; 489(4):375-380. PubMed ID: 28559139
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of selective cyclooxygenase-2 inhibitor lumiracoxib on human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Honjo H; Iwamoto K
Drug Metab Pharmacokinet; 2010; 25(5):450-5. PubMed ID: 20877132
[TBL] [Abstract][Full Text] [Related]
15. Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate.
Mizuno N; Takahashi T; Iwase Y; Kusuhara H; Niwa T; Sugiyama Y
Drug Metab Dispos; 2007 Aug; 35(8):1429-34. PubMed ID: 17502342
[TBL] [Abstract][Full Text] [Related]
16. Cumulative organic anion transporter-mediated drug-drug interaction potential of multiple components in salvia miltiorrhiza (danshen) preparations.
Wang L; Venitz J; Sweet DH
Pharm Res; 2014 Dec; 31(12):3503-14. PubMed ID: 24962510
[TBL] [Abstract][Full Text] [Related]
17. The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1.
Whitley AC; Sweet DH; Walle T
Drug Metab Dispos; 2005 Aug; 33(8):1097-100. PubMed ID: 15870380
[TBL] [Abstract][Full Text] [Related]
18. Potential for food-drug interactions by dietary phenolic acids on human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11).
Wang L; Sweet DH
Biochem Pharmacol; 2012 Oct; 84(8):1088-95. PubMed ID: 22877817
[TBL] [Abstract][Full Text] [Related]
19. Organic anion transporters involved in the excretion of bestatin in the kidney.
Zhu Y; Meng Q; Wang C; Liu Q; Sun H; Kaku T; Liu K
Peptides; 2012 Feb; 33(2):265-71. PubMed ID: 22273603
[TBL] [Abstract][Full Text] [Related]
20. Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins.
Kimura H; Takeda M; Narikawa S; Enomoto A; Ichida K; Endou H
J Pharmacol Exp Ther; 2002 Apr; 301(1):293-8. PubMed ID: 11907186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
